SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs > Nektar Therapeutics (NKTR)

Bad link... try this one for AMLN [#msg-10433899]

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
SeriousMoney Member Profile
 
Followed By 30
Posts 7,965
Boards Moderated 5
Alias Born 04/05/05
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/21/2017 5:03:35 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/21/2017 4:58:37 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/21/2017 4:57:40 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/21/2017 4:53:08 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/21/2017 4:51:01 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/21/2017 4:47:54 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/21/2017 4:45:10 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/21/2017 4:42:18 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/21/2017 4:41:01 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 9/21/2017 4:39:44 PM
Nektar Therapeutics Appoints Biotechnology Executive Jeff Ajer as New Board Member "PR Newswire (US)" - 9/21/2017 4:30:00 PM
Nektar Therapeutics Announces Seven Abstracts Accepted for Presentation at 2017 Society for Immunotherapy of Cancer (SITC) 32... "PR Newswire (US)" - 9/20/2017 7:24:00 AM
Nektar Therapeutics Initiates PROPEL Clinical Study to Evaluate Combination of NKTR-214, a CD122-Biased Agonist, with TECENTR... "PR Newswire (US)" - 9/12/2017 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/8/2017 6:09:53 PM
Nektar Therapeutics Presents Clinical Data from Phase 3 SUMMIT-07 Study of NKTR-181, a First-in-Class Investigational Opioid ... "PR Newswire (US)" - 9/6/2017 6:00:00 PM
Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2017 Morgan Stanley Global Healthcare Conference i... "PR Newswire (US)" - 9/6/2017 9:15:00 AM
Nektar Therapeutics to Present Clinical Data from Phase 3 SUMMIT-07 Study of NKTR-181, a First-in-Class Investigational Opioi... "PR Newswire (US)" - 8/30/2017 9:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/25/2017 4:42:28 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/18/2017 7:07:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/18/2017 7:06:33 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/18/2017 7:06:04 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/18/2017 7:05:08 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/18/2017 7:04:31 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/18/2017 7:04:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/18/2017 7:03:12 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist